Back to top
more

iShares MSCI USA Momentum Factor ETF: (MTUM)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Nov 1, 2024 04:00 PM ET

$202.01 USD

202.01
614,634

-0.40 (-0.20%)

Volume: 614,634

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $201.70 -0.31 (-0.15 %) 7:58 PM ET

Zacks News

Sweta Jaiswal, FRM headshot

Momentum ETFs Looking Attractive Amid Latest Market Optimism

Wall Street is expected to continue gaining on optimism surrounding new economic data and third-quarter earnings releases, which point to recovery from the pandemic-induced slowdown.

Sweta Jaiswal, FRM headshot

Tap the Current Market Momentum With These ETF Strategies

Here we discuss certain ETF strategies to help investors gain from optimism surrounding the recovering U.S. economy from the pandemic-led slump despite surging delta variant cases.

Sweta Jaiswal, FRM headshot

Here's Why Momentum ETFs Are Looking Good Buys

Wall Street is expected to continue gaining on optimism surrounding new economic data releases, which point to recovery from the pandemic-induced slowdown.

Sanghamitra Saha headshot

Fed Less Likely to Taper Soon on Delta Concerns: ETFs to Buy

The Fed chief Powell has said that the central bank wants to see "substantial further progress" in terms of maximum employment and stability in price inflation before it would mull over lowering the bond purchases

Sweta Jaiswal, FRM headshot

ETF Strategies to Cheer the Dovish Fed Minutes

Here we discuss certain ETF strategies to help investors gain from optimism surrounding the Fed's dovish stance amid recovering U.S. economy from the pandemic-led slump.

Sweta Jaiswal, FRM headshot

Try These ETF Strategies to Play the Market Optimism for 2H21

Here we discuss certain ETF strategies to help investors gain from the optimism surrounding the expectations of a strong Wall Street run in the second half of 2021.

Sweta Killa headshot

Momentum ETFs & Stocks to Buy Now

Momentum investing would be a winning strategy for those seeking higher returns in a short spell.

Sanghamitra Saha headshot

Fed Likely to Remain Dovish: ETFs to Buy

The Federal Reserve is likely to maintain its dovish stance in the upcoming meeting and also likely to take the same stand for at least the rest of this year, per a CNBC article.

Sweta Jaiswal, FRM headshot

ETF Strategies to Play the Drop in New US COVID-19 Cases

Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.

Sweta Jaiswal, FRM headshot

New Momentum ETF (QQQA) Hits the Market

Let's take a detailed look at the ProShares Nasdaq-100 Dorsey Wright Momentum ETF (QQQA) that was recently launched by the house of ProShares.

Sweta Jaiswal, FRM headshot

ETF Areas That Investors Can Consider for May

Considering the current market environment, we highlight some ETF areas for investors to bet on in May.

Sweta Jaiswal, FRM headshot

Top 3 Reasons Why You Should Bet on Momentum ETFs Now

Investors who want to gain from the steadily recovering U.S. economy can consider momentum ETFs.

Sweta Jaiswal, FRM headshot

ETF Strategies to Play the US Market Optimism

Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.

Sweta Jaiswal, FRM headshot

ETF Areas That Are Looking Attractive in April

Let's take a look at some ETF areas that are presenting some great investment opportunities for April considering the current market scenario.

Sweta Jaiswal, FRM headshot

Ride the Latest Fed Minutes Optimism With These ETFs

Here we highlight some ETFs for investors to gain from the optimism surrounding the minutes from the two-day Federal Open Market Committee (FOMC) meeting.

Sweta Jaiswal, FRM headshot

Momentum ETFs to Gain From the New Stimulus Optimism

Here we highlight some momentum ETFs that are lucrative investment picks keeping in mind the optimism surrounding Wall Street.

Sweta Jaiswal, FRM headshot

ETF Strategies to Gain From the Stimulus & Vaccine Optimism

Let's look at some ETF strategies to help investors gain from optimism surrounding another trench of coronavirus-aid package and coronavirus vaccine development.

Sweta Jaiswal, FRM headshot

Take a Look at These 5 ETFs to Ride the Market Bulls

It is being believed that the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout are making a strong case in favor of faster U.S. economic recovery in 2021.

Sanghamitra Saha headshot

Buy High-Beta & Momentum ETFs to Follow J.P. Morgan's Vision

The chief investment officer at JPMorgan Asset Management Bob Michele does not see overvaluation in Wall Street and suggested investors to join the rally.

Sweta Jaiswal, FRM headshot

Play These ETF Strategies to Ride the US Market Optimism

Let's look at some ETF strategies to help investors gain from optimism surrounding the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout.

Sweta Jaiswal, FRM headshot

3 Reasons Setting the Tone Right for Momentum ETFs

Here we highlight some momentum ETFs that are lucrative investment picks given the current market optimism.

Sweta Killa headshot

5 High Beta & Momentum ETFs to Tap the Santa Rally

These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.

Sweta Jaiswal, FRM headshot

Get Your Portfolio Christmas-Ready With These ETFs

Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.

Sweta Jaiswal, FRM headshot

Grab These ETFs Now for an Impressive Finish to 2020

Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.

Sweta Jaiswal, FRM headshot

ETF Strategies to Gain From Vaccine Hopes & Biden's Transition

Let's look at some ETF strategies to help investors gain from the upbeat coronavirus vaccine data amid the health crisis.